iiinova — where your digital self keeps evolving

Reposted by Marina Khan

SGRT Community @sgrtcommunity.bsky.social · 18/09/2026

In our September SGRTuesdays webinar, clinical teams from Royal Preston and Norfolk & Norwich Hospitals share their real-world experience using AlignRT v8.0 and its new Beam Guide module. Register here: sgrt.org/upcoming-mee...

011

Reposted by Marina Khan

American Society of Clinical Oncology @ascocancer.bsky.social · 16/09/2026

🎙 #EdBook EIC Dr. Gerald Hsu of @ucsfcancer.bsky.social & Dr. Christopher Booth of Queen's University discuss actionable strategies for clinicians to re-center cancer care on shared decision-making, transparent risk communication, & patient-centered care on #ByTheBook Podcast: bit.ly/3Vuahd5

034

Reposted by Marina Khan

Gerry Hanna @gerryhanna.bsky.social · 19/08/2026

At St Luke's Radiation Oncology Network we are seeking to appoint an outstanding individual as our Director of Physics. This is an exciting and key role. Come and be part of this brilliant, vibrant and ambitious ☘️radiotherapy community! 🔗 www.rezoomo.com/job/102220/

rezoomo.com

SLRON/08-2026/865 Director of Physics in Dublin | St. Luke's Radiation Oncology Network Jobs

St. Luke's Radiation Oncology Network is looking to fill the role of SLRON/08-2026/865 Director of Physics in Dublin. Apply today!

031

Reposted by Marina Khan

The BMJ @bmj.com · 04/07/2026

A new BMJ Analysis finds a UK-US trade deal could cost the NHS a potential £45bn in drug spending and nearly 300 000 excess deaths in 10 years. The deal sacrifices UK health and wealth, contrary to the rhetoric of government ministers, says @kamranabbasi.bsky.social

bmj.com

£45bn and 300 000 deaths: the UK’s anniversary gift to the US

Two hundred and fifty years after liberation from British colonialism, the United States is co-hosting the football World Cup. The US might even win it for the first time—although France, its former a...

25247

Reposted by Marina Khan

BTOG @btog.bsky.social · 17/06/2026

Programme released! Register now for BTOG's Small Cell Lung Cancer event in London: Diagnosis, stages, and key controversies. www.btog.org/btog-small-cell-lung-c…

011

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 12/06/2026

📢Final webinar in the Re-RT series! Join us for Reirradiation and the Patient Voice and discover how patient perspectives can shape future reirradiation research. 📅22 June | 15:00–16:00 CEST ESTRO HUB bit.ly/44aJaot #PatientVoice #RadiationOncology

021

Reposted by Marina Khan

Ananya Choudhury @achoud72.bsky.social · 15/05/2026

I came to #ESTRO26 yesterday, but here's the @mcrcnews.bsky.social Manchester posse flying today. Apparently some escaped the photo! 🥳 @estroradiotherapy.bsky.social @oncoalert.bsky.social

182

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 17/05/2026

🏆 Celebrating excellence in radiation oncology. From the Jens Overgaard Legacy Award to the Regaud Medal and Breur Award, ESTRO recognises outstanding contributions shaping the future of our field. Discover this year’s awardees and their inspiring work.

031

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 15/05/2026

✨ Starting #ESTRO26 with over 700 participants joining today’s pre-meeting courses and our newly launched Clinical Bootcamp! An exciting start to the congress week ahead in Stockholm!

042

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 07/05/2026

Published in the #GreenJournal: ESTRO clinical practice #guideline on #radiotherapy for adult soft tissue #sarcoma of the extremities and trunk wall – Endorsed by @astro-org.bsky.social 👉 bit.ly/3PmGlNv

011

Reposted by Marina Khan

American Association for Cancer Research (AACR) @theaacr.bsky.social · 15/03/2026

Day 3 of the AACR Special Conference on Innovations in Kidney Cancer Research will feature plenary sessions on modeling disease as well as oncogenes and tumor suppressors. #AACRkidney26

043

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 03/03/2026

#ESTRO consensus guidelines on #GTV delineation and dose-escalation in #rectalcancer, published in ctRO, Clinical and Translational Radiation Oncology. 👉 bit.ly/4cnC4me #openaccess #radiotherapy #radiationoncology #guideline

012

Reposted by Marina Khan

ALK Positive Lung Cancer UK @alkpositiveuk.bsky.social · 01/03/2026

ALK+ #lungcancer often means staying on a TKI for years. If radiotherapy is needed for brain metastases or a growing spot, the big question is whether to continue the drug. New ESMO–ESTRO guidance says combining them can increase side effects. #LCSM www.sciencedirect.com/science/arti...

071

Reposted by Marina Khan

American Association of Physicists in Medicine @aapmhq.bsky.social · 01/03/2026

NOTABLE ARTICLE, January 2026 #MedicalPhysics: A generalizable dose prediction model for automatic radiotherapy planning based on physics‐informed priors and large‐kernel convolutions aapm.onlinelibrary.wiley.com/doi/10… Please join us in congratulating Tianyu Xiong et al

011

Reposted by Marina Khan

BTOG @btog.bsky.social · 19/02/2026

At #BTOG26, consultants will host a Career Development Session for Trainees - An informal session for trainees of any grade interested in a career in thoracic oncology: Ask questions and chat to consultants from different specialties, all experienced in mentoring and career advice. Sanjay Popat

011

Reposted by Marina Khan

UT MD Anderson Cancer Center @mdanderson.bsky.social · 04/02/2026

On World Cancer Day, we honor everyone who’s been touched by cancer. We’re announcing a new traveling museum exhibition, The Journey to End Cancer: From Cause to Cure, presented by MD Anderson. Join us on the journey to end cancer. spr.ly/63327hynKT #OncSky #EndCancer

051

Reposted by Marina Khan

European Organisation for Research and Treatment of Cancer @eortc.org · 30/01/2026

Why does funding for clinical research matter? Because #ClinicalTrials depend on sustained investment to advance cancer treatment and provide better outcomes for patients. 👉 Like and reshare this message to highlight why cancer research matters. #WorldCancerDay #EORTCimpact #CancerResearch

011

Reposted by Marina Khan

Cancer Research UK @cancerresearchuk.org · 17/01/2026

We’re pleased that abiraterone can now be offered to thousands more men affected by prostate cancer. Read more about this decision and what it means: cruk.ink/3LzxTbS

Blue text graphic with black and white text which reads: 'Thousands more men in England offered abiraterone, one of our prostate cancer breakthroughs'

0125

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 30/12/2025

📣 ESTRO 2026 Pre-Meeting Webinars Get ready for #ESTRO26 with two online pre-meeting webinars ahead of the congress in Stockholm (15–19 May 2026). Cases will be discussed — we can’t wait to engage with you! 🔗 Info & registration: bit.ly/4pAM9PH #PMCwebinars #ESTRO26

034

Reposted by Marina Khan

International Psycho-Oncology Society (IPOS) @ipospsychooncol.bsky.social · 16/12/2025

As part of the World Cancer Day 2026 campaign, IPOS is hosting an insightful webinar to spotlight the key findings from the recently published Lancet Oncology Commission report, “The Human Crisis in Cancer.” Free for everyone ipos-society.org/event-6480465

043

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 01/12/2025

📢 Join the ESTRO course in Rome to boost your skills in SRS/SRT for brain metastases & skull base lesions! 📅 26–28 March 2026 ⏰ Early deadline: 7 Jan 2026 👨‍🏫 Course Director: Maximilian Niyazi 🔗 Register: bit.ly/44BetJJ #ESTROSchool26 #SRS #SRT #Radiotherapy

012

Reposted by Marina Khan

Jen L, PhD @drjkyl.bsky.social · 21/11/2025

Effectiveness of Chemotherapy Plus Immunotherapy and Molecular Alterations in Advanced Biliary Tract Cancer: Real-World Evidence From a Single-Center Australian Cohort @cancer-control.bsky.social @journals.sagepub.com journals.sagepub.com/doi/10.1177/... #carcinoma #biomarkers #oncology #prognosis

023

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 10/10/2025

🗣️ New #ESTROWebinar! Management of SCLC in the Immunotherapy Era 🗓 5 Nov | 17:00–18:00 CET Chaired by Prof Corinne Faivre-Finn & Dr Suraiya Dubash (UK) 💻 Live Q&A with experts! More info & Registration here: 👉 bit.ly/3KAbjPB #RadiationOncology #LungCancer #SCLC #Immunotherapy #Webinar

021

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 10/10/2025

📢 The first-ever ESTRO Clinical Workshop is coming to Vienna | 12–13 Mar 2026! Spots are limited—don’t miss out. 📌 Submit your motivational statement by 22 Oct to secure your place. 💻 Apply now 👉 bit.ly/47wlj5G #ESTROCLIN26 #ClinicalWorkshop #RadiationOncology

022

Reposted by Marina Khan

BTOG @btog.bsky.social · 09/10/2025

💡 Discover the latest in mutation-driven lung cancer research. Session 4 with @ruthstraussfdn.bsky.social rings science, debate, and progress together. 📅 13 Nov | 📍 The View, London 🔗 www.btog.org/non-smo... #LungCancer #LCSM #NonSmokingLungCancer

033

Reposted by Marina Khan

UK Oncology Nursing Society @ukons.bsky.social · 28/09/2025

Calling all Young and Early Career Cancer Nurses (YECCN) The YECCN MIG is currently looking for 1x MIG Chair, 1x secretary and 8x committee members. If interested & under 35/working for <5yrs, please email by 5th October, a 300 word expression of interest to: ukons@media1productions.co.uk #YECCN

011

Reposted by Marina Khan

American Society of Clinical Oncology @ascocancer.bsky.social · 19/09/2025

Exciting news! We’ve launched ASCO Edge, an online oncology practice management educational series exclusively available to ASCO members. Get started today: brnw.ch/21wVVu3

022

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 12/09/2025

Quality assurance in the randomized multicentre phase III trial EORTC-1709-BTG/CCTG CE.8 (MIRAGE) for glioblastoma: Results of the #radiotherapy delineation benchmark case procedure, published in the Green Journal. 👉 Read it before your patients: bit.ly/4fLoatJ

032

Reposted by Marina Khan

Clive Peedell @drpeedell.bsky.social · 11/09/2025

New #radiotherapy innovations are being stifled by the tortuous commissioning process. Patients deserve better! #radonc #oncology #medtwitter Postcode lottery for new cancer treatments, doctors warn - BBC News www.bbc.co.uk/news/article...

bbc.co.uk

Postcode lottery for new cancer treatments, doctors warn

Experts say bureaucracy is

1111

Reposted by Marina Khan

EORTC Quality of Life Group (QLG) @qol.eortc.org · 11/09/2025

📢 Attending #EAPM2025 this week? Today, our @eortc.org #QualityofLife Group member Ines Rathgeber will report on the development of an e-learning course focusing on the use of EORTC PRO measures for quality of life assessment in clinical practice 👇 eapm.eu.com/2025-eapm-co... #CancerResearch

011

Reposted by Marina Khan

Let's Win Pancreatic Cancer @letswinpc.org · 04/09/2025

✅ Finished treatment or on maintenance for #PancreaticCancer? We’ve got resources to help. Find tips on managing side effects, eating well, coping with scanxiety, and staying up to date on the latest research. bit.ly/4lX0owd #GuideToAction #LetsWinPC

bit.ly

Living With

You may be undergoing maintenance treatment or you may have completed treatment but you are still part of the pancreatic cancer community.

011

Reposted by Marina Khan

Dr Laura Charlesworth [PhD] @lcharlesworth.bsky.social · 01/08/2025

Putting Patients First: Transforming Cancer Diagnosis, Treatment and Care Through Patient-Centred Approaches. In this guest editorial, we reflect on why meaningful progress & the delivery of high quality cancer care requires more than technical innovation www.radiographyonline.com/article/S107...

radiographyonline.com

Putting patients first: Transforming cancer diagnosis, treatment and care through patient-centred approaches

Delivering high quality care is at the forefront of the cancer agenda for professionals and policy makers alike. Whilst it is clear that drug development alongside technical innovations and advancemen...

021

Reposted by Marina Khan

BTOG @btog.bsky.social · 01/08/2025

Today on #WorldLungCancerDay, we reaffirm our mission to support thoracic oncology professionals and advocate for equitable, world-class care for all patients. Together, we strive to match the best survival rates globally. 💙 #WLCD2025 #LungCancerAwareness #LCSM #lungcancer

021

Reposted by Marina Khan

Giorgio Seano @giorgioseano.bsky.social · 17/07/2025

🧠 Why does glioblastoma always outsmart treatment? In our #Neuro-Oncology paper, we identified proneural-mesenchymal hybrid glioblastoma cells that are resistant to therapy and dependent on nuclear import. doi.org/10.1093/neuo... Short walkthrough below. Let’s dive in! 🧵 (1/9) #GBM, #BrainTumor

Background: Despite extensive research efforts, glioblastoma (GBM) remains a deadly disease with poor prognosis. Although previous studies have identified various cell states within GBM tumors, the molecular mechanism underlying adaptive GBM cell plasticity induced by conventional therapy remains unclear.
Methods: We used fluorescent reporters for proneural (PN) and mesenchymal (MES) subtypes to monitor GBM cell plasticity in real-time across multiple patient-derived cell lines. This approach revealed cells that concurrently expressed both proneural and mesenchymal markers. To investigate this unique hybrid population, we implemented a comprehensive methodological approach encompassing bulk and single-cell RNA sequencing, single-cell ChIP sequencing, nuclear proteomics, high-resolution imaging, orthotopic mouse models, clinical dataset analysis, and pharmacological and genetic techniques. This multifaceted strategy allowed us to gain functional and molecular insights into this distinct cellular population.
Results: We showed that these hybrid cells are increased by conventional therapies, and are resistant to these therapies. At the molecular level, hybrid cells display significant alterations in chromatin structure and nuclear protein composition, elevated transcriptional activity, Myc activation, and improved transport between the nucleus and cytoplasm. Genetic and pharmaceutical inhibition of the nuclear import/export shuttling machinery, increased in hybrid cells, effectively suppressed adaptive GBM cell plasticity and hybrid identity, thereby enhancing the sensitivity of GBM cells to therapies.
Conclusion: Our results indicate that GBM hybrid cells play a crucial role in chemoradiation resistance. The nuclear transport machinery presents a potential therapeutic target for hybrid cells, offering a way to counteract the typical resistance to treatment observed in GBM.

2146

Reposted by Marina Khan

Dr Liz O’Riordan @lizoriordan.bsky.social · 19/07/2025

BREAKING NEWS Scientists at the @icr-ctsu.bsky.social have discovered how to predict which ER+ HER2+ cancers have a higher risk of recurrence in just 2 weeks! Breaking news - Breast Cancer Breakthrough! #breastcancer youtube.com/shorts/3rYUU...

youtube.com

Breaking news - Breast Cancer Breakthrough! #breastcancer

YouTube video by Dr Liz O'Riordan

34613

Reposted by Marina Khan

Stephen Tozer-Loft @to-lo.co.uk · 19/07/2025

important listen for all involved in #radiotherapy. pca.st/episode/a767...

pca.st

"Captain Kirk Forgot to put the Machine on Stun"

142

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 17/07/2025

✨Today is #BrachytherapyAwarenessDay, let's spotlight precision in cancer care. 🎯#Brachytherapy boosts survival, helps preserve function & QoL, yet remains underused. 📢 Oncology professionals: ✅ Raise awareness ✅ Support access ✅ Empower patients 👉https://bit.ly/4lwRdTL

021

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 03/07/2025

At #ESTRO25, a heated debate unfolded: “CBCT-based fast adaptation workflows will supersede MR-Linac usage.” 💬 With strong arguments on both sides, the audience shifted from 72% in favour to a near 50/50 split by the end. 👉 bit.ly/3Iavy59

011

Reposted by Marina Khan

European Society for Radiotherapy and Oncology (ESTRO) @estroradiotherapy.bsky.social · 26/06/2025

Congratulations to our journal TipsRO - Technical Innovations and Patient Support in Radiation Oncology for achieving its first Impact Factor of 2.8! A reflection of the quality and dedication of the editorial team, authors, and the entire #RTT community.

012

Reposted by Marina Khan

Patty Diez @pattydiezh.bsky.social · 24/06/2025

A really educational day. Big shoutout to Tom Rackley & Rebecca Muirhead for leading the event & superstars @alison-tree.bsky.social and Dione Lother for sharing their wisdom. Amazing practical insights from @aileenduffton.bsky.social @marina-khan.bsky.social Helen Grimes & Joe Flaherty. Congrats!

061

Marina Khan @marina-khan.bsky.social · 24/06/2025

We had the SABR bone and nodes workshop today. @uksabr.bsky.social in collaboration with the RCR. Lots of discussion & learning for all within the SABR MDT. Collaboration at its best. Thank you to all those that attended and especially the speakers. @alison-tree.bsky.social @pattydiezh.bsky.social

031